|
Market Closed -
Nasdaq
05:00:01 21/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.240 USD | -6.77% |
|
-11.43% | -91.67% |
| Market Cap | 12.64M 11.51M 10.61M 9.65M 18.11M 1.17B 19.03M 129M 51.32M 639M 47.43M 46.43M 2.01B | P/E 2026 * |
-0.26x | P/E 2027 * | -0.64x |
|---|---|---|---|---|---|
| Enterprise Value | 12.64M 11.51M 10.61M 9.65M 18.11M 1.17B 19.03M 129M 51.32M 639M 47.43M 46.43M 2.01B | EV / Sales 2026 * |
6.32x | EV / Sales 2027 * | 30x |
| Free-Float |
88.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MCRB | Delayed | |
| MCRB | Real-time | ||
| 1S90 | Delayed | ||
| 1S90 | Delayed | ||
| 1S90 | Real-time | ||
| 1S90 | Real-time |
Last Transcript: Seres Therapeutics, Inc.
| 1 day | -6.77% | ||
| 1 week | -11.43% | ||
| Current month | -29.94% | ||
| 1 month | -46.09% | ||
| 3 months | -72.81% | ||
| 6 months | -84.60% | ||
| Current year | -91.67% |
| 1 week | 1.2 | 1.7 | |
| 1 month | 1.2 | 2.26 | |
| Current year | 1.2 | 16.42 | |
| 1 year | 1.2 | 18.86 | |
| 3 years | 1.2 | 41 | |
| 5 years | 1.2 | 233.8 | |
| 10 years | 1.2 | 770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Kender
CEO | Chief Executive Officer | 70 | 02/03/2026 |
Matthew Henn
PSD | President | 51 | 02/03/2026 |
Dennis Walling
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Kender
CHM | Chairman | 70 | 02/03/2026 |
Eric Shaff
BRD | Director/Board Member | 50 | 15/01/2019 |
Dennis Ausiello
BRD | Director/Board Member | 80 | 01/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/8/26 | Sell | General Counsel | -82 | 0.0008% | ||
| 17/8/26 | Sell | Director | -263 | 0.0027% | ||
| 17/8/26 | Sell | Chief Operating Officer | -64 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.77% | -11.43% | -93.00% | -94.07% | 12.64M | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.89B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -1.91% | -2.47% | +20.46% | +153.08% | 40B | |
| Weighted average by Cap. | -1.48% | -2.04% | +31.83% | +155.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2M 1.82M 1.68M 1.53M 2.86M 185M 3.01M 20.43M 8.12M 101M 7.5M 7.35M 317M | 422K 384K 354K 322K 604K 39.08M 635K 4.31M 1.71M 21.34M 1.58M 1.55M 66.99M |
| Net income | -47.4M -43.17M -39.78M -36.19M -67.89M -4.39B -71.35M -484M -192M -2.4B -178M -174M -7.52B | -52.83M -48.12M -44.34M -40.33M -75.67M -4.89B -79.53M -540M -214M -2.67B -198M -194M -8.39B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | US$1.240 | -6.77% | 57,062 |
| 19/11/26 | US$1.330 | -7.64% | 54,689 |
| 18/11/26 | US$1.440 | +2.13% | 42,969 |
| 17/11/26 | US$1.410 | 0.00% | 55,575 |
| 16/11/26 | US$1.410 | +0.71% | 186,619 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MCRB Stock
Select your edition
All financial news and data tailored to specific country editions
















